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Abstract
Background: Despite bacteraemia is present in the majority of patients with pneumococcal, little
is known about the influence of the systemic infection on the meningeal inflammatory response.
Methods: To explore the role of systemic infection on the meningeal inflammation, experimental
meningitis was induced by intracisternal injection of ~1 × 106 CFU Streptococcus pneumoniae, type
3, and the 26 rabbits were either provided with ~1 × 106 CFU S. pneumoniae intravenously at 0
hour ("bacteraemic" rabbits, n = 9), immunized with paraformaldehyde-killed S. pneumoniae for 5
weeks prior to the experiment ("immunized" rabbits", n = 8), or not treated further ("control"
rabbits, n = 9). WBC and bacterial concentrations were determined in CSF and blood every second
hour during a 16 hours study period together with CSF IL-8 and protein levels. We also studied
CSF and blood WBC levels in 153 pneumococcal meningitis patients with and without presence of
bacteraemia.
Results: As designed, blood bacterial concentrations were significantly different among three
experimental groups during the 16 hours study period (Kruskal Wallis test, P < 0.05), whereas no
differences in CSF bacterial levels were observed (P > 0.05). Blood WBC decreased in bacteraemic
rabbits between ~10–16 hours after the bacterial inoculation in contrast to an increase for both
the immunized rabbits and controls (P < 0.05). The CSF pleocytosis was attenuated in bacteraemic
rabbits as compared to the two other groups between 12–16 hours from time of infection (P <
0.017), despite accelerated CSF IL-8 levels in bacteraemic rabbits.
In patients with pneumococcal meningitis, no significant difference in CSF WBC was observed
between patients with or without bacteraemia at admission (n = 103, 1740 cells/µL (123–4032) vs.
n = 50, 1961 cells/µL (673–5182), respectively, P = 0.18), but there was a significant correlation
between CSF and blood WBC (n = 127, Spearman rho = 0.234, P = 0.008).
Conclusion:  Our results suggest that a decrease in peripheral WBC induced by enhanced
bacteraemia in pneumococcal meningitis results in an attenuated CSF pleocytosis.
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Background
Streptococcus pneumoniae meningitis is characterized by an
accumulation of leukocytes within the subarachnoidal
space. It has been suggested that host inflammatory reac-
tions to the invading pathogen are largely responsible for
the poor outcome of pneumococcal meningitis, because
pathophysiological alterations leading to death continue
to evolve after the bacterial eradication by antibiotic ther-
apy [1,2]. Therefore, the mechanisms behind the regula-
tion of the pleocytosis have been studied carefully during
the last three decades, and adjunctive therapy has pre-
dominantly been designed to decrease the harmful effect
of the meningeal inflammatory response (e.g. dexameth-
asone in clinical trials [3] and various anti-inflammatory
strategies in preclinical testing [1,2]). Recent studies may,
however, reveal a less important role of the meningeal
inflammatory response and a more significant role of the
systemic infection/inflammation on the mortality of
pneumococcal meningitis, i.e: 1) patient with a low
number of CSF WBC were at an increased risk of dying
from pneumococcal meningitis [4]. 2) Blocking of leuko-
cyte entry into the CSF increased the mortality in experi-
mental pneumococcal meningitis most likely due to an
augmented bacteraemia [5]. 3) Bacteraemia was present
in 2 of every three patient with pneumococcal meningitis,
and a large number of these patients had septic shock with
systemic complications accounting for approximately half
of the death from the disease [4]. 4) The beneficial effect
of anti-inflammatory therapy with dexamethasone was
predominantly observed on systemic complications than
on neurological complications [6].
Cytokine expression is widely upregulated in the brain
after intravenously LPS injection [7], but no pleocytosis is
observed, and CSF cytokine levels are either not detectable
or significant lower than the corresponding blood con-
centrations [8]. Conversely, cytokines are locally released
in the CSF during meningitis [8,9] with undetectable or
insignificant corresponding blood levels, which had led to
the current opinion that the meningeal inflammatory
response is not influenced by the events taking place
within the systemic compartment. On the other hand, no
studies have to our knowledge addressed the influence of
an altered blood bacterial load on the meningeal inflam-
matory response during meningitis. Moreover, alterations
in the systemic inflammatory response (e.g. leukopenia
induced by cyclophosphamide [10,11], depletion of sys-
temic monocytes [12], increase in number of neutrophils
by G-CSF pretreatment [9]) showed an influence on the
meningeal inflammatory response during experimental
pneumococcal meningitis. Thus, several aspects of how
the systemic infection/inflammation influences the
meningeal inflammatory response during pneumococcal
meningitis still remain to be defined.
The aim of the present study was hence to examine to
which extend the presence of bacteraemia affects the CSF
pleocytosis in patients with pneumococcal meningitis
and during the early course of experimental pneumococ-
cal meningitis. To enhance the level and onset of bacter-
aemia during the course of experimental meningits,
pneumococci were concomitantly injected intravenously,
and to remove the bacteraemia that accompanies the
meningitis, we used active immunization of rabbits.
Methods
Experimental pneumococcal meningitis
For the meningitis experiments, rabbits were infected
intracisternally with ~1 × 106 CFU serotype 3 S. pneumo-
niae, essential as previous described [9]. CSF and blood
samples were obtained every second hour during a 16-
hours study period and were analyzed for bacterial con-
centrations by quantitative cultures (lower detection level:
50 CFU/ml) and WBC on an automatic cell counter (Swe-
lab, Åstad, Sweden). After centrifugation, CSF superna-
tants were analyzed for IL-8 using a rabbit specific ELISA
and for protein content using the Lowry method [9].
Study design
In addition to the induced meningitis, rabbits were
divided into three groups: 1) "Bacteraemic" comprised of
9 rabbits that were given ~1 × 106 CFU serotype 3 S. pneu-
moniae intravenously at the time of the intracisternal inoc-
ulation. 2) "Immunized" comprised of 8 immunized
rabbits. To obtain a significant humoral response against
pneumococci, the rabbits were immunized by intrave-
nously injection of paraformaldehyde-killed serotype 3 S.
pneumoniae (1 ml of a 3–6 × 109 CFU/ml bacterial suspen-
sion (Statens Serum Institut, vaccine lot. #E31), three
times per week for ~5 weeks). The serotiter was deter-
mined after the immunization has ended and before the
start of the meningitis experiment, using the Neufeld cap-
sule reaction [13]. In brief, a two-fold dilution in isotonic
NaCl of serum obtained from immunized rabbits was
mixed together with 6 × 109 CFU/ml serotype 3 S. pneumo-
niae (1:1). The serotiter was determined as the reciprocal
of the highest dilution with a visible quelling reaction and
was found to be 4 (n = 1), 8 (n = 6) and 16 (n = 1). 3) Con-
trols comprised of 9 infected control rabbits without addi-
tional intervention.
Patients with pneumococcal meningitis
153 patients with pneumococcal meningitis, who had
available CSF WBC counts from a diagnostic lumbar
puncture taken at admission, were included. The 153
patients were part of 187 consecutive patients from a Dan-
ish nationwide study, and patients characteristics has
been presented in detail previously [4]. All 153 patients
had available blood culture data, whereas 127 out of 153
patients had available blood WBC data. Meningitis wasBMC Infectious Diseases 2006, 6:78 http://www.biomedcentral.com/1471-2334/6/78
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defined as a CSF culture with S. pneumoniae or CSF pleo-
cytosis (>10 leukocytes/mL) in conjunction with a blood
culture of S. pneumoniae.
Ethics
All human protocols were approved by the local scientific
ethic committee and the Danish Data Protection Agency
(#2002-41-2278). The Danish Animal Experiment
Inspectorate (Dyreforsøgstilsynet) approved all experi-
mental protocols.
Statistically analysis
All results are given as medians (25/75 percentiles). Com-
parison between the 3 experimental groups was per-
formed by Kruskal-Wallis Test, and when significant it was
followed by Mann-Whitney test with Bonferroni's correc-
tion for multiple comparisons. Multivariate ANOVA
(MANOVA) with repeated measures was used on selected
data to further explore generated relations. Correlation
between parameters was performed by non-parametic
Spearman rank test. P < 0.05 was considered significant,
except when Bonferronis correction was used (P < 0.017).
GraphPad Prism, version 4.01, GraphPad Software Inc.,
San Diego, CA, USA was used for all statistical analysis
except MANOVA (SAS/JMP Software, version 5.1, SAS
institute Inc, Cary, NC, USA).
Results
Experimental pneumococcal meningitis
As per the study design, blood bacterial concentrations
were significantly different between the three groups at 2–
16 hours after the bacterial inoculation (Figure 1, top,
Kruskal Wallis test, P < 0.05). All bacteraemic and control
rabbits developed secondary bacteraemia, whereas immu-
nized rabbits never develop bacteraemia during the 16-
hour study period (Figure 1, top). The bacteraemic group
developed detectable bacteraemia earlier (at ~2 hours)
than control rabbits, where bacteraemia was first seen
after 6 hours, thus having consistently higher blood bac-
terial concentrations than control rabbits during the 16
hours study period. Subsequent MANOVA analysis con-
firmed these results (data not shown).
CSF bacterial concentrations
No statistically significant difference in CSF bacterial con-
centrations was found between the 3 groups during the
16-hour study period (Figure 1, bottom, Kruskal Wallis
test, P > 0.05). Subsequent MANOVA analysis confirmed
these results and overall, there was no significant influ-
ence of group (MANOVA, P = 0.418), but there was an
effect of time and interaction between groups and time
(both MANOVA. P < 0.001). Based upon comparisons to
2 h post CSF infection, bacteraemic rabbits had initially
the highest growth rate (~1 Log10 CFU/mL between 2–10
hours), whereas between 10–16 hours a net decrease in
CSF bacterial concentrations were observed. In contrast,
immunized rabbits had apparently no significant bacte-
rial growth within the CSF, whereas controls had a steady
increase in CSF bacterial concentrations of ~1 Log10 CFU/
mL during the 16-hour study period. This difference
between groups reached significance by hour 14
(MANOVA, P < 0.003), and at 16 hours the immunized
group had a significantly lower CSF bacterial concentra-
tions than the control group (MANOVA, P = 0.008).
CSF and blood WBC concentrations
CSF WBC counts were significantly different between the
3 groups from start of the pleocytosis at ~10–12 hours
until the end of the 16-hours study period (Figure 2, top,
CSF and blood bacterial concentration during experimental  pneumococcal meningitis Figure 1
CSF and blood bacterial concentration during exper-
imental pneumococcal meningitis. *Significant differ-
ence between groups (Kruskal Wallis test, P < 0.05). There 
was a significant higher blood bacterial concentration in 
bacteraemic rabbits (n = 9) than in controls (n = 9) at 2–6 
and 12 hours and than in immunized rabbits (n = 8) at 2–16 
hours, respectively, and higher in controls than in immunized 
rabbits at 10–16 hours (Mann Whitney test, P < 0.017). All 
data are shown as medians (25–75 percentiles).BMC Infectious Diseases 2006, 6:78 http://www.biomedcentral.com/1471-2334/6/78
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Kruskal Wallis test, P < 0.05). Bacteraemic rabbits had sig-
nificantly lower CSF WBC counts as compared to controls
and to immunized rabbits (Mann-Whitney test, P  <
0.017), whereas no statistically significant difference was
observed between controls and immunized rabbits
(Mann Whitney test, P > 0.017). Similarly, the blood WBC
counts varied significantly between the three groups from
8 hours and onwards with significant difference between
the three groups at 8 hours and between 12–16 hours
(Figure 2, bottom, Kruskal Wallis test, P < 0.05). Controls
had an elevation in blood WBC counts from ~8 hours
after the bacterial inoculation, immunized rabbits devel-
oped leukocytosis slightly later than control rabbits, how-
ever with no statistical differences between the two groups
(Mann Whitney test, P > 0.017). Conversely, bacteraemic
rabbits developed a consistent decrease in blood WBC
counts from 10 hours with significantly lower WBC levels
as compared to controls at 8 hours and between 12–16
hours and to immunized rabbits between 12–16 hours,
respectively (Mann Whitney test, P < 0.017). Subsequent
MANOVA analysis confirmed these results (data not
shown).
Not surprisingly, there was a significant correlation
between CSF and blood WBC over time or when all three
groups were included in the analysis due to alterations in
these parameters over time or between groups (data not
shown). However, there was a positive correlation
between CSF and blood WBC (rho>0.38), reaching statis-
tical significance at 14 hours (p = 0.001), when analysing
the two groups that were not significantly different (con-
CSF and blood WBC concentration during experimental  pneumococcal meningitis Figure 2
CSF and blood WBC concentration during experi-
mental pneumococcal meningitis. *Significant difference 
between groups (Kruskal Wallis test, P < 0.05). Bacteraemic 
rabbits (n = 9) had significantly lower CSF WBC counts as 
compared to controls (n = 9) and to immunized rabbits (n = 
8) between 12–16 hours (Mann Whitney test, P < 0.017). 
Bacteraemic rabbits had significantly lower blood WBC levels 
as compared to controls at 8 hours and between 12–16 
hours and to immunized rabbits between 12–16 hours, 
respectively (Mann Whitney test,P < 0.017). All data are 
shown as medians (25–75 percentiles).
CSF IL-8 and protein concentration during experimental  pneumococcal meningitis Figure 3
CSF IL-8 and protein concentration during experi-
mental pneumococcal meningitis. All data are shown as 
medians (25–75 percentiles). *Significant difference between 
groups (Kruskal Wallis test, P < 0.05).BMC Infectious Diseases 2006, 6:78 http://www.biomedcentral.com/1471-2334/6/78
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trols and immunized rabbits), regarding CSF and blood
WBC levels.
CSF IL-8 and protein concentrations
CSF IL-8 levels were higher in bacteraemic rabbits as com-
pared to immunized rabbits and control rabbits (Figure 3,
top) from ~12–16 hours after the bacterial inoculation,
however with only statistical significance between bacter-
aemic and immunized rabbits at 12 hours (1718 ng/L
(735–4731) vs. 450 ng/L (188–693), respectively, Mann
Whitney test, P = 0.011). Compared to hour 0 all groups
had an increase in CSF IL-8 levels during the study period,
and at 16 hours there was a significant difference between
groups (MANOVA, P < 0.023). No significant difference
in CSF protein levels was observed between the three
groups during the 16-hour study period (Figure 3 bottom,
Kruskal Wallis test, P > 0.05). Subsequent MANOVA anal-
ysis confirmed these results (data not shown).
Patients with pneumococcal meningitis
Positive CSF cultures were detected in 146 out of 153
patients (95%), whereas a positive blood culture was
present in 103 out of 153 patients with pneumococcal
meningitis (67%). There was no significant difference in
CSF WBC between patients with a positive or a negative
blood culture (1740 cells/µL (123–4032) vs. 1961 cells/
µL (673–5182), respectively, Mann Whitney test, P  =
0.18) in contrast to a significant correlation between CSF
WBC and blood WBC (Figure 4, n = 127, Spearman test,
rho = 0.234, P = 0.008). No significant association was
found between other CSF routine parameters (protein –
and glucose levels) and blood WBC counts/presence of
bacteraemia (data not shown).
Discussion
In the present study, inducing bacteraemia during the
early part of experimental pneumococcal meningitis was
associated with attenuation of the development of CSF
pleocytosis despite accentuated concentrations of the
chemokine IL-8 in the CSF. The attenuated CSF pleocyto-
sis associated with the early onset bacteraemia was likely
due to a decrease in blood WBC induced by the bacterae-
mia as opposed to directly caused by the bacteraemia per
se, since the avoidance of bacteraemia by active immuni-
zation against pneumococci did neither affect the CSF ple-
ocytosis nor blood leukocytosis as compared to controls.
Further supporting the explanation that the decrease in
blood WBC, induced by the early onset bacteraemia, was
responsible for the attenuated CSF pleocytosis observed
experimentally, we found a significant correlation
between blood WBC and CSF WBC counts in patients
with pneumococcal meningitis, which was in contrast to
no association between presence of bacteraemia and
number of CSF WBC.
Several studies have previously documented an altered
leukocyte function during endotoxemia (e.g. decreased in
chemotactic activity of neutrophils toward various chem-
otactic signals [14] including IL-8 [15], shedding of neu-
trophil receptors such as IL-8-receptor [16] and L-selectin
[17]), resulting in a decreased migration of leukocytes to
extravascular infection foci (e.g. lung [18], peritoneum
[19], skin [20]). Additionally, we have shown an attenu-
ated pleocytosis during endotoxemia in LPS-induced
meningitis [O'Reilly T, ∅stergaard C, Vaxelaire J, and Zak
O: Systemic inflammation alters the inflammatory response in
experimental LPS-induced meningitis (manuscript submit-
ted for publication)], whereas only sparse information
has been generated about the influence of pneumococcal
bacteraemia on the recruitment of leukocytes to local
infections sites. In contrast to our results, Sato et al. [21]
found no significant difference in number of alveolar neu-
trophils during pneumococcal pneumonia between
bacteraemic rabbits and non-bacteraemic rabbits, despite
a significant decrease in peripheral neutrophils in bacter-
aemic rabbits, which was a result of an increased seques-
tration of neutrophils in the lung [22]. Not surprisingly
caused an elimination of peripheral leukocytes by cyclo-
phosphamide an attenuated pleocytosis in experimental
pneumococcal meningitis [10,11], but also an altered
neutrophil function with pneumococcal bacteraemia
could be of importance, since a decreased chemotactic
ability of neutrophils with G-CSF pretreatment [9] and a
blocking of adhesion molecules [23] has been associated
with an attenuated pleocytosis.
In the present study, CSF IL-8 levels were higher in bacter-
aemic animals, whereas no alteration in CSF IL-8 levels
was found in immunized rabbits as compared to controls.
Correspondent CSF and blood WBC concentrations in  patients with pneumococcal meningitis Figure 4
Correspondent CSF and blood WBC concentrations 
in patients with pneumococcal meningitis. Correlation 
between CSF and blood WBC: all patients (n = 127, rho = 
0.234, P = 0.008), patients with a positive blood culture (n = 
89, rho = 0.272, P = 0.01) and patients with a negative blood 
(n = 38, rho = 0.159, P = 0.34). No significant difference in 
CSF WBC between patients with a positive or a negative 
blood culture (P > 0.05).BMC Infectious Diseases 2006, 6:78 http://www.biomedcentral.com/1471-2334/6/78
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Also, an attenuation of leukocyte entry into the CSF by the
selectin-blocker, Fucoidin resulted in enhanced CSF IL-8
levels [23]. IL-8 is a chemokine locally produced during
meningitis and has an essential role in the recruitment of
neutrophils into the CSF [24,25]. Our results suggest that
a novel feedback mechanism involving blood derived leu-
kocytes that control the CSF production of IL-8 as a local
chemotactic signal, which is accordance with findings
from a rat pneumonia model, where MIP-2, the IL-8 ana-
log in rats, was higher in alveolar fluid during cyclophos-
phamide-induced leukopenia [26]. However, a lower
degree of IL-8 binding to the IL-8 receptor on CSF neu-
trophils could also explain the finding of higher IL-8 lev-
els in CSF supernatants from rabbits with an attenuated
pleocytosis.
CSF bacterial concentrations were not affected by altera-
tion in the blood bacterial load confirming previous find-
ings from the rabbit model that an enhancement of the
humoral immune response did not affect the CSF bacte-
rial load during the early phase of pneumococcal menin-
gitis [27]. Moreover, the attenuated CSF pleocytosis in
bacteraemic rabbits did not influence CSF bacterial con-
centrations confirming that the CNS is a compartment
distinct from the systemic circulation regarding host
defense mechanisms against invading bacteria
[9,11,23,24]. No significant difference in CSF protein lev-
els was observed between the three groups, indicating that
the blood/brain barrier permeability was not influenced
by the degree of bacteraemia, but conflicting with previ-
ous findings showing that an attenuated pleocytosis was
associated with a decreased blood-brain barrier break
down [23,28].
Conclusion
We found a significant correlation between CSF WBC and
blood WBC in patients with pneumococcal meningitis
and that CSF pleocytosis was attenuated with a decrease in
peripheral WBC as a consequence of an earlier onset
bacteraemia in experimental pneumococcal meningitis.
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